Dr. Zyad Kafri, MD

Dr. Kafri practices at Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Kafri's NPI, 1083747976, was assigned on March 13, 2007. Dr. Kafri graduated from Damascus University Faculty of Medicine in 1997. Dr. Kafri holds Michigan license 4301077923.

Dr. Kafri's primary practice is Henry Ford St. John Hospital, at 22101 Moross Rd, Detroit, MI 48236 in Wayne County. The practice phone is (313) 343-4000.

Dr. Kafri's primary practice is Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Kafri is also affiliated with Henry Ford Hospital. The medical group on file is Henry Ford St. John Hospital. Dmand AI also links Dr. Kafri to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kafri practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kafri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kafri is board certified in hematology by the American Board of Internal Medicine. Dr. Kafri is licensed in Michigan.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Kafri treats.

CMS data shows 862 Medicare services from Dr. Kafri across 10 procedure codes in 2024, for 308 Medicare patients. Medicare paid $59,022 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 308 Medicare patients who saw Dr. Kafri in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kafri's median patient age at 70, with 52% women.

In 2024, Dr. Kafri wrote 2,014 Medicare Part D claims for 278 patients. 73% of them were for generic drugs. CMS names the drug for 1,632 of them, across 52 drugs with 11 or more claims each, at $5,487,578 in total drug cost. In 2023, CMS named 1,372 claims across 44 drugs.

Dr. Kafri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Kafri, published from 2012 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Anticoagulants. Dr. Kafri has published most often in Case Rep Gastroenterol. Dr. Kafri's most frequent co-authors are Tarik Hikmat Hadid, MD, Ayad M. Al-Katib, MD and Uqba Khan, MD.

CMS Open Payments shows 74 general payments to Dr. Kafri from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 63% of the total. Eli Lilly and Company paid the most, $251.

Dmand AI lists 2 awards for Dr. Kafri, most recently Teacher of the Year Award in 2017.

Dr. Kafri graduated from Damascus University Faculty of Medicine in 1997.

Dr. Kafri is in network with 15 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.